- uniQure Announces Proposed Public Offering... such as hemophilia B, Huntington's disease and congestive heart failure, today announced that it has commenced an underwritten public offering of ... read more
- uniQure Says New Data From Mouse Models Show Treatment for Huntingtons Disease Holds …uniQure NV (QURE) said early Wednesday new preclinical data from AMT-130, the company's proprietary gene therapy candidate for the treatment of ... read more
- Virtual Tour Explains Challenges of DementiaThere are a large number of recognized diseases associated with dementia—Huntington's disease, Parkinson's, Wernicke-Korsakoff Syndrome, Lewy ... read more
- Voyager Therapeutics Reports Positive Data for AAV Gene TherapyAdditionally, in Huntington's disease, the company's clinical candidate VY-HTT01, composed of an AAV capsid and proprietary transgene, resulted in ... read more
- Key Researchers at Leerink Swann Kept their ‘Outperform’ rating for uniQure NV (NDAQ:QURE …... results for patients suffering from genetic and other severe diseases. ... AMT-130 in Huntington's Disease” with publication date: October 18, 2017. ... read more
- uniQure NV (NDAQ:QURE) Outperform Rating Reconfirmed Today By Leerink Swann; The Price …... Data on AMT-130 in Huntington's Disease” published on October 18, 2017, Livetradingnews.com published: “Uniqure NV (NASDAQ:QURE) Stock is ... read more
- In focus: Six Citizen Jane filmmakers to set your sights on... and in Lucy Walker's documentary short “The Lion's Mouth Opens,” in which Palka dealt with the possibility of a Huntington's Disease diagnosis. ... read more
- Aimee BrownTwo years were completed before symptoms of Huntington's Disease prevented her from continuing. She participated in several clinical studies ... read more
- Fighting a lion-sized disease through a lambHuntington's Disease is a dirty thief. It robs the people it strikes of their minds and bodies in the form of muscle coordination loss, abnormal writhing ... read more
- Is Uniqure NV (QURE)’s Fuel Running Low? The Stock Reaches 52-Week High Today... Divergence”, Streetinsider.com published: “uniQure (QURE) Announces New Preclinical Data on AMT-130 in Huntington's Disease” on October 18, ... read more
- Is Buying Uniqure NV (QURE) Here a Winning Strategy?... Streetinsider.com which released: “uniQure (QURE) Announces New Preclinical Data on AMT-130 in Huntington's Disease” on October 18, 2017, ... read more
- Uniqure NV (QURE) Sets 52-Week High; Strong Momentum for Holders... in Huntington's Disease”, Livetradingnews.com published: “Uniqure NV (NASDAQ:QURE) Stock is Looking at a Bearish Divergence” on October 20, ... read more
- Seymour wants NZ to follow Australian moves toward voluntary euthanasiaFor instance, he explained, somebody with later stage Huntington's disease. He thinks it shows that New Zealand is falling behind and neglecting ... read more
- Huntington’s Disease Therapeutics Market 2017-2021: Global Market Report with Vendors …Huntington's Disease Therapeutics Market report delivers a detailed study with present and upcoming Opportunities to clarify the future investment in ... read more
- Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Systemic SclerodermaThis chronic autoimmune disease causes severe fibrosis of the skin and ... Its second, EHP-102, is focused on treating Huntington's disease and ... read more
- In The Spotlight: UniQureuniQure's pipeline consists of adeno-associated virus (AAV)-based gene therapies for hemophilia B, Huntington's disease and cardiovascular disease ... read more
- Harnessing patient communitiesAnd when they're facing a health crisis or ongoing illness, more people ... and potentially life-long afflictions such as psoriasis, Huntington's disease, ... read more
- What to know about the future of medical marijuana in Pennsylvania... Huntington's Disease, inflammatory bowel disease, intractable seizures, Multiple Sclerosis, neuropathies, Parkinson's Disease, post-traumatic stress ... read more
- Jeff Leibow’s annual NF Hope concert is growing beyond Las VegasIt affects approximately 128,000 people, more common than cystic fibrosis, hereditary muscular dystrophy, Huntington's disease and Tay Sachs ... read more
- New Scientist Conference: To infinity and beyond!Have you wondered whether diseases can be curedfixed for good? Do you know ... George Huntington first discovered this genetic disease, stating:. ... read more
- Next Weeks Broker Price Targets For Uniqure BV (NASDAQ:QURE)The Company's product candidates within the Core Program include AMT-060 for Hemophilia B, AMT-130 for Huntington's disease and S100A1 for ... read more
- What’s Next for Uniqure NV (QURE) After Today’s Huge Increase?... Streetinsider.com, which released: “uniQure (QURE) Announces New Preclinical Data on AMT-130 in Huntington's Disease” on October 18, 2017. ... read more
- Uniqure NV (QURE)’s Stock Is Buy After Today’s Big IncreaseStreetinsider.com's article titled: “uniQure (QURE) Announces New Preclinical Data on AMT-130 in Huntington's Disease” and published on October ... read more
- Community plans 5K to support family affected by Huntington’s DiseaseITHACA, N.Y. — This weekend, there will be a 5K to benefit a local family that has been deeply affected by Huntington's Disease. The community is ... read more
- Cowen Shines Light on Uniqure NV (QURE) as the Latter Advances Padua Variant AMT-061 into …... and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. ... read more
- Molecular Interactions Study May Advance Insight into Huntington’s Disease ProcessesResearchers have come up with a new method to study the interactions between cell components that are thought to be defective in patients with ... read more
- Voyager Presents New Data in AAV Gene Therapy for ALS at European Conference... diseases besides ALS, such as Friedreich's ataxia, advanced Parkinson's disease, a monogenic form of ALS, Huntington's disease, and dementia. ... read more
- Singapore grants patent to Suven for neuro molecule... stages of pre-clinical development targeting conditions such as ADHD, dementia, depression, Huntington's disease, Parkinson's disease and pain. ... read more
- Singapore grants patent to Suven for neuro molecule... with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and ... read more
- uniQure Strengthens Intellectual Property Portfolio with Acquisition of Patent Family Providing …... of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington's disease and cardiovascular diseases. www.uniQure.com. ... read more
- Ixico Annual Earnings To Beat Expectations On Strong Revenue GrowthIt cited new multi-year contracts signed in the year, including an Alzheimer's Disease clinical trial in July and two new contracts in Huntington's ... read more
- uniQure Strengthens Intellectual Property Portfolio with Acquisition of Patent Family Providing …... a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington's disease and cardiovascular diseases. www. ... read more
- Voyager Therapeutics (VYGR) Earning Somewhat Positive Press Coverage, Analysis Finds... a monogenic form of amyotrophic lateral sclerosis (ALS); Huntington's disease; Friedreich's ataxia; frontotemporal dementia/Alzheimer's disease, ... read more
- Order boost means IXICO ends year strongly... used in a number of clinical trials across a broad range of neurodegenerative diseases such as Alzheimer's, Parkinson's, PSP and Huntington's. ... read more
- Trading StatementNew multi-year contracts signed in the year include an Alzheimer's Disease clinical trial announced in July and two new contracts in Huntington's ... read more
- 38 Biggest Movers From YesterdayuniQure will offer preclinical data on AMT-130 in Huntington's disease at ESGCT Congress. Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) shares ... read more
- CRISPR: From yogurt to Friedreich’s AtaxiaFriedreich's Ataxia is a neurodegenerative disease that occurs from a recessive inherited gene that progressively damages the nervous systems and ... read more
- Benitec Biopharma’s shares ride higher after securing new US patentBenitec has also licensed ddRNAi to other biopharmaceutical companies for applications including HIV/AIDS, Huntington's Disease, chronic ... read more
- Celebrating 50 Years of the Huntington’s Disease Society of AmericaLouise Vetter, President and CEO of the Huntington's Disease Society of America (HDSA), doesn't like to commemorate milestones. It's hard, though ... read more
- Interlaken Community Raises Funds for Local GirlBarlow has Huntington's Disease, a neurodegenerative disorder that her father also had. To help Barlow's mother, Addie, keep up with the necessary ... read more
- 32 Stocks Moving In Wednesday’s Mid-Day SessionuniQure will offer preclinical data on AMT-130 in Huntington's disease at ESGCT Congress. Transenterix Inc (NYSE: TRXC) shares declined 13 ... read more
- Can analysts adopt a bullish outlook for Uniqure NV (NASDAQ:QURE)?Globenewswire.com's news article titled: “uniQure Announces FDA Orphan Drug Designation for AMT-130 in Huntington's disease” with publication ... read more
- Community BriefsGenova travels the world speaking about neurological diseases including Alzheimer's disease, traumatic brain injury, autism, Huntington's disease ... read more
- Readers question photons colliding, black sea snakes and moreOnline reader Glenn wondered if drugs for Parkinson's disease and Huntington's disease that help with movement problems could also remedy ... read more
- Gene Therapy for HD Continues to Show PromiseUsing the R6/2 mouse model of Huntington's disease, the administration of AMT-130 into the mouse striatum led to significant improvements in motor ... read more
- Parkinson’s Experts Become Co-directors of New York University Movement Disorders InstituteHe was an investigator on more than 30 clinical trials of potential treatments for Parkinson's and Huntington's disease, and is in the midst of leading a ... read more
- Technical Indicator Analysis for Voyager Therapeutics, Inc. (NASDAQ:VYGR)... VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington's disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics ... read more
- uniQure Presents New Preclinical Data on AMT-130 in Huntington’s Disease at the ESGCT 25th …Data from the study demonstrate that following administration of AMT-130 in Huntington's disease mouse models, significant improvements in both ... read more
- uniQure Presents New Preclinical Data on AMT-130 in Huntington’s Disease at the ESGCT 25th …LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 18, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene ... read more
- Suven Life Sciences secures a product patent in Singapore... with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson, and ... read more
RSS Feed – News
HDinHD > RSS Feed – News
